Cargando…
AddaVax Formulated with PolyI:C as a Potential Adjuvant of MDCK-based Influenza Vaccine Enhances Local, Cellular, and Antibody Protective Immune Response in Mice
Poor immune responses to inactivated influenza vaccine can be improved by effective and safe adjuvants to increase antibody titers and cellular protective response. In our study, AddaVax and PolyI:C combined adjuvant (AP adjuvant) were used for influenza vaccine development. After immunizing BALB/c...
Autores principales: | Nian, Xuanxuan, Zhang, Jiayou, Deng, Tao, Liu, Jing, Gong, Zheng, Lv, Chuanshuo, Yao, Luyao, Li, Junying, Huang, Shihe, Yang, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584644/ https://www.ncbi.nlm.nih.gov/pubmed/34766215 http://dx.doi.org/10.1208/s12249-021-02145-0 |
Ejemplares similares
-
Kinetic of the Antibody Response Following AddaVax-Adjuvanted Immunization with Recombinant Influenza Antigens
por: Ross, Ted. M., et al.
Publicado: (2022) -
Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas
por: Mazumder, Suparna, et al.
Publicado: (2022) -
MPLA and AddaVax(®) Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis
por: Oliveira-Maciel, Diogo, et al.
Publicado: (2021) -
Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
por: Perera, Dilhan J., et al.
Publicado: (2020) -
AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses
por: Gao, Feixia, et al.
Publicado: (2022)